Tracking cardiovascular device inventory in cath labs, electrophysiology (EP) labs and operating rooms (ORs) can be a ...
Researchers at the Australian Nuclear Science and Technology Organisation (ANSTO) have led the development of a new method for producing positron emission tomography (PET) radiotracers. The discovery utilizes the transition metal rhenium to promote fluorine-18 radiolabelling under aqueous, low temperature conditions.
Recent clinical study data presented at the American College of Cardiology (ACC) 2017 meeting show new treatment ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world setting, according to the 12-month results of the BIOFLEX PEACE all-comers registry. The findings were presented this week at the Charing Cross Symposium, April 25-28 in London. Outcomes of the BIOLUX 4EVER study were also presented on the main stage, revealing 12-month results numerically comparable to drug-eluting stents (DES) when the Pulsar-18 was used in combination with the Passeo-18 Lux drug-coated balloon (DCB).
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American ...
Wentworth-Douglass Hospital in Dover, N.H., installed Toshiba Medical’s Infinix-i Sky + angiography system in its endovascular hybrid operating room (OR). Wentworth-Douglass is using the system to diagnose and treat a wide range of vascular disorders, such as aneurysms and peripheral vascular disease.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The vacancy rate for radiographers increased to 4.2 percent in 2017, according to the latest American Society of Radiologic Technologists (ASRT) Radiologic Sciences Staffing and Workplace Survey.
Mercator MedSystems Inc. announced the first patient enrollment into the TANGO (Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee) clinical trial. TANGO will study the effects of using Mercator’s proprietary Bullfrog Micro-Infusion Device for the adventitial delivery of the drug Torisel (temsirolimus) after revascularization of lesions below the knee (BTK) in patients with critical limb ischemia (CLI).
A new Varicose Vein Registry has begun producing useful outcomes information, as reported in the May edition of the Journal of Vascular Surgery: Venous and Lymphatic Disorders. The registry is a joint effort by the Society for Vascular Surgery, the Vascular Quality Initiative and the American Venous Forum. It was launched in January 2015 and was set up to track systematically the outcomes of various treatments for varicose veins, ultimately providing guidance for both consumers and treating physicians.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Boston Scientific announced results from the RANGER SFA trial for the Ranger Paclitaxel-Coated PTA Balloon Catheter at the Charing Cross Symposium, in London. Data demonstrated that the drug-coated balloon (DCB) exhibited both a high rate of primary patency and freedom from target lesion revascularization (TLR) at 12 months, reducing the need for re-interventions to re-establish flow in previously blocked blood vessels.
The issues surrounding congenital coronary anomalies and their effect on sudden death are complex. Researchers are still trying to fully understand anomalous aortic origin of a coronary artery (AAOCA) and its relationship to adverse health outcomes in humans, especially children. Using the most up-to-date literature, as well as the input of leading experts in the field, the American Association for Thoracic Surgery (AATS) has released practical guidelines for the identification and treatment of AAOCA, including an overview of the latest data surrounding population-based risk.
Repeated cycles of weight loss and gain may be linked to higher risk for stroke, heart attack and death in people with pre-existing coronary artery disease, according to a study published online in the New England Journal of Medicine.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
April 25, 2017 — Corindus Vascular Robotics Inc. announced a strategic partnership with BLOXR Solutions, provider of ...
AtriCure Inc. announced it has sold more than 100,000 AtriClip Left Atrial Appendage Exclusion System devices worldwide. This makes it the most widely used of all devices for excluding the left atrial appendage (LAA), according to the company.
April 24, 2017 — Offering a full range of advanced clinical applications for researchers, Toshiba Medical will ...